Does lifting weights protect muscle on the weight-loss drug tirzepatide?

Original study: Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial
Daniel J. Green, Andrew Haynes, Destiny R. Underwood, Evangeline R. Winterton, Abbey A. Green, Robin M. Daly, Elena S. George, Leanne Lester, Louise H. Naylor, Graham S. Hillis, P. Gerry Fegan, Bu B. Yeap
Nature Medicine November 9, 2026
What the researchers wanted to know
In adults losing weight on the drug tirzepatide, does weight training three times a week reduce the muscle and other lean tissue they lose, compared with tirzepatide without weight training?
Why it matters
Weight-loss drugs like tirzepatide and semaglutide help people lose a lot of weight, but part of what they lose is lean tissue, which includes muscle. Losing muscle can make people weaker, especially as they get older. No trial had tested whether weight training protects muscle while people take one of these drugs.
Tirzepatide (sold as Mounjaro and Zepbound) is a weekly injection that cuts appetite and leads to large weight loss. It belongs to the same family as semaglutide (Ozempic and Wegovy).
When anyone loses weight, by any method, part of the loss is lean tissue: everything in the body that is not fat or bone, mostly muscle and water. In earlier drug trials, lean tissue made up around a quarter of the weight people lost.
The muscle that matters most for getting around is in the arms and legs.
120 adults aged 50 to 70 in Perth, Australia, took part: 60 men and 60 women past menopause. They had obesity, or were overweight with a related condition such as high blood pressure, and did less than an hour of exercise a week. People with diabetes or heart disease were not included.
Everyone got a weekly tirzepatide injection for 40 weeks, starting at 2.5 mg and rising every 4 weeks toward 15 mg. Everyone was told to keep up their protein, fluids, fruit and vegetables. They were then randomly split into two groups:
- Tirzepatide plus weight training (59 people): three supervised 1-hour gym sessions a week, with weights increased over time. Sessions used squats, deadlifts, leg press, pulldowns, chest press and similar exercises, moving from lighter technique work to harder strength and muscle-building work.
- Tirzepatide only (61 people): carried on with their usual activities.
Body fat and lean tissue were measured with a body scan every 8 weeks, by an analyst who did not know who was in which group. Strength was tested on the bench press, lat pulldown and knee extension, and blood pressure, blood sugar and cholesterol were checked.
Both groups lost the same amount of weight and fat, but the weight-training group lost less lean tissue and got stronger, while the drug-only group got weaker.
After 40 weeks:
- Weight: both groups lost about 22 kg (22.6 kg drug only, 22.3 kg with weight training)
- Fat: both lost about 17 to 18 kg
- Lean tissue: the drug-only group lost 4.7 kg and the weight-training group 3.6 kg, so weight training cut the lean loss by 1.1 kg, about a quarter
- Lean tissue in arms and legs: 3.6 kg lost with the drug only, against 2.9 kg with weight training
Most of the lean loss happened in the first 24 weeks and then levelled off.
Change in strength:
- Bench press: down 8% with the drug only, up 11% with weight training
- Lat pulldown: down 7%, against up 16%
- Knee extension: down 9%, against up 18%
The gap between the groups was 19% to 23% on each lift, or 9 to 13 kg.
Blood pressure (the top number fell by 15 to 17 mm Hg), blood sugar, cholesterol and blood fats improved about equally in both groups, so weight training added nothing there. People made 91% of their training sessions, and 93% finished the study. About half felt sick at some point, and about a third had vomiting, constipation, diarrhea or indigestion, equally in both groups.
Conclusion
Weight training three times a week on tirzepatide cut the loss of lean tissue by about a quarter and made people stronger instead of weaker, while weight and fat loss stayed the same.
Therefore
Weight training could be an effective add-on for people taking tirzepatide to lose weight.
How much can you trust this study?
Two studies can say the same thing and deserve very different amounts of trust. LayMed scores every study out of 100 on:
- Study design
- Bias Control & Transparency
- Size and precision
- Measurement
LayMed Plus members see the Study Quality score for every study, with the reason behind each part.
Get LayMed Plus$7.99 a month or $79 a year
How far does this apply to you personally?
A study can earn a high quality score and still not apply well to you. How much its results carry over to you can change a lot depending on your sex, age, race or ethnicity, body weight, genes, hormones, blood pressure and resting heart rate, health conditions, medications, activity level, training experience, diet, sleep, smoking and drinking, job and gut bacteria.
Hover over or tap any of these to see a real study where it changed the results.
LayMed Plus members get a personal Relevance score for every study. It weighs all of these factors to estimate how well the results apply to you and your life.
Get LayMed Plus$7.99 a month or $79 a year
Important new studies, explained in plain English, sent straight to your inbox.
Almost done. Please check your email for a confirmation sent from "laymed@dr-gains.com".
Last checked against the source: November 18, 2026
Update November 18, 2026: Written to the LayMed article standard from the full published paper.
LayMed articles are plain-English summaries of published research, written for education. They are not medical advice. Always read the original study and talk to a qualified professional about your own situation.